THORENS is a pharmaceutical product primarily used for the treatment and management of osteoporosis, a condition characterized by weakened bones that are more prone to fractures. It contains active ingredients that help to increase bone density and strength, thereby reducing the risk of bone fractures. THORENS works by influencing the bone formation and resorption process, promoting the development of healthier bone tissue. It is typically prescribed to individuals at high risk of osteoporosis, including postmenopausal women and older adults, who are more susceptible to bone density loss. Patients are advised to follow their healthcare provider's instructions regarding dosage and administration to ensure optimal effectiveness and minimize potential side effects.